Anixa Biosciences
ANIX
58 hedge funds and large institutions have $16M invested in Anixa Biosciences in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 7 closing their positions.
72% more call options, than puts
Call options by funds: $122K | Put options by funds: $71K
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
18% more capital invested
Capital invested by funds: $13.6M → $16M (+$2.48M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 57 → 58 (+1)
0.74% less ownership
Funds ownership: 18.15% → 17.41% (-0.74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$217K |
| 2 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$51.5K |
| 3 |
SG Americas Securities
New York
|
+$44.4K |
| 4 |
LPL Financial
San Diego,
California
|
+$40K |
| 5 |
BlackRock
New York
|
+$35.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$342K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$251K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$247K |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$162K |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$41.7K |
ANIX Hedge Fund Activity: Q1 2025 in Review
58 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2025, worth a combined $16M — up 18% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ANIX positions and 7 closed out — a net gain of 1 holder — while 11 added to existing stakes and 7 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $217K. The largest seller was Long Focus Capital Management, exiting entirely with an estimated $342K sold.
- 58 institutional investors held Anixa Biosciences (ANIX) as of Q1 2025, up from 57 in Q4 2024.
- Funds reported $16M of Anixa Biosciences stock for Q1 2025, up 18% quarter-over-quarter.
- 8 funds opened new Anixa Biosciences positions in Q1 2025 and 7 closed out, a net change of +1 holder.
- The largest Anixa Biosciences buyer in Q1 2025 was GSA Capital Partners, an estimated $217K added.
- The largest Anixa Biosciences seller in Q1 2025 was Long Focus Capital Management, an estimated $342K sold.
Based on aggregated 13F filings for Q1 2025.